Pioneering the development of AI-enabled platform for in-vivo real-time cancer diagnosis, thus improving timely medical interventions
Endofotonics
MISSION
Provide real-time early gastrointestinal cancer diagnosis
VISION
Reduce cancer burden through earlier diagnosis
Company
incorporated
2013
MILESTONES
2014
Angel
round raised
IMDx lab
prototype developed
2015
2016
Pre-Series
A round raised
IMDx
probe developed
2017
SPECTRA IMDx™ developed
& subsidiary in Shanghai, China set up
2019
IMDx
engineering
prototype developed
2018
2020
Commence clinical trials
Sales outside China
2021
2022
Sales within China
.....................
.....................
.....................
........
|
|
Singapore Main Office
67 Ayer Rajah Crescent, #03-01/02
LaunchPad @ onenorth, Singapore 139950
China, Shanghai Office
R51, 14th Floor, 800 Shangcheng Road,
Pudong District, Shanghai
For any enquiries, please write to contact@endofotonics.com and we will get back to you as soon as
possible.
Disclaimer: Endofotonics products shown in this website may not be registered, approved for sale, or available for purchase in all countries where the website is accessible. Please consult your local Endofotonics representative for more information. Prior to undergoing esophago-gastro-duodenoscopy (EGD) procedures, please consult your healthcare professional to provide you with the possible risk and benefits associated with SPECTRA
IMDx™ System.